Clinical Trials Directory

Trials / Unknown

UnknownNCT01645020

Comparison Between Two Types of Meshes Used in Pelvic Organs Prolapse Procedures

Status
Unknown
Phase
Study type
Observational
Enrollment
240 (estimated)
Sponsor
Western Galilee Hospital-Nahariya · Other Government
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

Using partially absorbed meshes in pelvic reconstructive surgery will involve fewer postoperative complications especially less pain caused by the mesh mass.

Detailed description

Weakness of pelvic floor support is the cause defects and damage to pelvic organs functioning and urinary control and it has a pretty common occurrence. It was suggested recently that the event is considered a hernia that requires mesh use, which reduces return rates following pelvic floor repair. Mesh use is known to cause complications and unwanted side effects, such as chronic pain, vaginal network exposure and infection. The degree of complications is related directly to the mass of the mesh, and that's why the absorbable meshes were developed.Two months after the surgery with absorbable mesh, the mass left in the patient's body is half of the initial mesh mass and according to our assumption this effect will minimize the extent and intensity of mesh complications compared with conventional ones. During the study we will examine medical records of women who have had surgery with pelvic floor reconstructive meshes. The cases will be divided according to the mesh type being used. A polypropylene mesh (single strand and tunneling wide) trade name "Prolift", and similar mesh that contains approximately half of the network mass after being dissolves in two months, a trade name "Prolift +" M. The number of participants in each group is 120 women. The post-operative follow-up examination will include three points in time. After a month, six months and a year later. In addition to questionnaires in order to quantify the degree of urinary disturbance, pain after surgery and sexual function.

Conditions

Timeline

Start date
2008-08-01
Primary completion
2013-01-01
Completion
2013-06-01
First posted
2012-07-19
Last updated
2012-07-19

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01645020. Inclusion in this directory is not an endorsement.